SELZENTRY is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is Maraviroc.
| Product ID | 49702-237_3d3637cd-c64c-497d-80f0-7c010dea09ac |
| NDC | 49702-237 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SELZENTRY |
| Generic Name | Maraviroc |
| Dosage Form | Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-11-04 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208984 |
| Labeler Name | ViiV Healthcare Company |
| Substance Name | MARAVIROC |
| Active Ingredient Strength | 20 mg/mL |
| Pharm Classes | CCR5 Co-receptor Antagonist [EPC],Chemokine Co-receptor 5 Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2016-11-04 |
| Marketing End Date | 2024-10-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA208984 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-11-04 |
| Ingredient | Strength |
|---|---|
| MARAVIROC | 20 mg/mL |
| SPL SET ID: | 46f30ac5-c96b-429e-976d-8c5ee1c0761b |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 49702-223 | SELZENTRY | maraviroc |
| 49702-224 | SELZENTRY | maraviroc |
| 49702-233 | SELZENTRY | maraviroc |
| 49702-235 | SELZENTRY | maraviroc |
| 49702-237 | SELZENTRY | maraviroc |
| 49702-260 | SELZENTRY | maraviroc |
| 50090-1486 | SELZENTRY | maraviroc |
| 50090-6238 | SELZENTRY | maraviroc |
| 31722-579 | Maraviroc | Maraviroc |
| 31722-580 | Maraviroc | Maraviroc |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SELZENTRY 77183318 3372315 Live/Registered |
PHIVCO-1 LLC 2007-05-17 |